Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Injection timing affects nausea intensity significantly
Retatrutide is being investigated for metabolic dysfunction-associated steatotic liver disease (MASLD) and its more advanced inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH), alongside obesity and type 2 diabetes
NEJM 389:2221
Substances such as berberine, which has glucose-lowering properties, or stimulant-based fat burners, could interact unpredictably with retatrutide's metabolic effects
US$ 22.02
US$ 27.11
US$ 25.30
US$ 23.40
US$ 29.32
US$ 26.28
US$ 26.07
US$ 21.20
US$ 26.10
US$ 20.33
US$ 26.68
